April 19, 2017 / 12:19 PM / 5 months ago

BRIEF-Flex Pharma presents human efficacy data on FLX-787

April 19 (Reuters) - Flex Pharma Inc:

* Flex Pharma presents human efficacy data on FLX-787 at the American Academy of neurology annual meeting

* Flex Pharma - data from first treatment exposure of 26 subjects showed statistically significant effect in reducing cramp frequency compared to placebo

* Phase 2 studies planned for flx-787 to initiate in us this summer in ALS and Charcot-Marie-Tooth Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below